Safety profile of therapeutic pox virus-based vaccines for cancer
Howard L. Kaufman(Rutgers, The State University of New Jersey), Thomas Schuetz(Dana-Farber Cancer Institute), Rosanna Di Paola(University of Messina), Jeffrey Schlom(National Cancer Institute), Dennis Panicali(Fox Chase Cancer Center), Margaret von Mehren(Temple University Health System), John Marshall(Columbia University), Howard Streicher(National Cancer Institute), H. Kim Lyerly(Duke University)
Cited by 1
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Oncolytic viruses: a new class of immunotherapy drugs
|Nature Reviews Drug Discovery|2015|1.6k
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k